| Gene symbol | MET | Synonyms | AUTS9, DA11, DFNB97, HGFR, RCCP2, c-Met | Type of gene | protein-coding |
| Chromosome | 7 | Map location | 7q31.2 | dbXrefs | |
| Gene perturbation-related omics dataset | PerturbAtlas | PertOrg | ||||
| Description | MET proto-oncogene, receptor tyrosine kinase | ||||
| GTO ID | GTC1697 |
| Trial ID | NCT03060356 |
| Disease | Malignant Adenoma | Breast Cancer |
| Altered gene | c-MET |
| Therapeutic/Target gene | Target gene |
| Therapy | CAR-T cell |
| Treatment | cMet CAR-T cells |
| Generation | 2nd |
| Phase | Early_Phase1 |
| Recruitment status | Terminated |
| Title | Autologous T Cells Expressing MET scFv CAR (RNA CART-cMET) |
| Year | 2016 |
| Country | United States |
| Company sponsor | University of Pennsylvania |
| Other ID(s) | UPCC 11916, 825376 |
| Vector information | |||||
|
|||||
| Cohort 1 | |||||||||||
|
|||||||||||